Roberta Daidone's Books

IEEE 802.15.4 and ZigBee as Enabling Technologies for Low-Power Wireless Systems with Quality-of-Service Constraints

By: Stefano Tennina,Anis Koubâa,Roberta Daidone,Mário Alves,Petr Jurčík,Ricardo Severino,Marco Tiloca,Jan-Hinrich Hauer,Nuno Pereira,Gianluca Dini,Mélanie Bouroche,Eduardo Tovar

Write a review Read reviews Take a Quiz Solve Book Puzzle

IEEE 802.15.4 and ZigBee as Enabling Technologies for Low-Power Wireless Systems with Quality-of-Service Constraints

By: Stefano Tennina,Anis Koubâa,Roberta Daidone,Mário Alves,Petr Jurčík,Ricardo Severino,Marco Tiloca,Jan-Hinrich Hauer,Nuno Pereira,Gianluca Dini,Mélanie Bouroche,Eduardo Tovar

This book outlines the most important characteristics of IEEE 802.15.4 and ZigBee and how they can be used to engineer Wireless Sensor Network (WSN) systems and applications, with a particular focus on Quality-of-Service (QoS) aspects. It starts by providing a snapshot of the most relevant features of these two protocols, identifying some gaps in the standard specifications. Then it describes several state-of-the-art open-source implementations, models and tools that have been designed by the authors and have been widely used by the international community. The book also outlines the fundamental performance limits of IEEE 802.15.4/ZigBee networks, based on well-sustained analytical, simulation and experimental models, including how to dimension such networks to optimize delay/energy trade-offs.

Average ratings

N/A

Write a review

Solve jigsaw puzzle

Age

Page Count

173

Publisher

Springer Science & Business Media

Published Date

ISBN 10

3642373682

ISBN 13

9783642373688

Trends in Angiogenesis Research

By: Roberta V. Zubar

Write a review Read reviews Take a Quiz Solve Book Puzzle

Trends in Angiogenesis Research

By: Roberta V. Zubar

Angiogenesis -- the growth of new blood vessels -- is an important natural process occurring in the body, both for health and as related to disease. Angiogenesis occurs in the healthy body to help heal wounds and to help restore blood flow to tissues after injury or insult. In females, angiogenesis also occurs during the monthly reproductive cycle (to rebuild the uterus lining, to mature the egg during ovulation) and during pregnancy (to build the placenta, the circulation between mother and foetus). The healthy body controls angiogenesis through a series of "on" and "off" switches. The main "on" switches are known as angiogenesis-stimulating growth factors. The main "off switches" are known as angiogenesis inhibitors. When angiogenic growth factors are produced in excess of angiogenesis inhibitors the balance is tipped in favour of blood vessel growth. When inhibitors are present in excess of stimulators, angiogenesis is stopped. The normal, healthy body maintains a perfect balance of angiogenesis modulators. In general, angiogenesis is "turned off" by the production of more inhibitors than stimulators. Tumour angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths, supplying nutrients and oxygen and removing waste products. Tumour angiogenesis actually starts with cancerous tumour cells releasing molecules that send signals to surrounding normal host tissue. This signalling activates certain genes in the host tissue that, in turn, cause proteins to encourage growth of new blood vessels. This new book examines its angiogenesis within the context of theory and its applications to cancer treatment.

Average ratings

N/A